Abstract
A series of 4,5-dihydro-1H-benzo[g]indazole-3-carboxamides (2a-k) as analogues of the previously reported CB2 ligands 6-chloro- and 6-methyl-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1, 4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) was synthesized and their affinity and selectivity towards CB1 and CB2 receptors were evaluated. Several of the new compounds (2a,b,c,d and i) exhibited CB 1 affinity in the nanomolar range with moderate or negligible affinity towards CB2 receptors. Compounds 2a and c increased intestinal propulsion in mouse. Their pro-kinetic effects were reversed by the reference CB agonist CP-55,940. Consequently, in vivo CB1 antagonistic activity was highlighted for these compounds. © 2005 Elsevier Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Murineddu, G., Ruiu, S., Mussinu, J. M., Loriga, G., Grella, G. E., Carai, M. A. M., … Pinna, G. A. (2005). Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors. Bioorganic and Medicinal Chemistry, 13(9), 3309–3320. https://doi.org/10.1016/j.bmc.2005.02.032
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.